Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 6
2014 7
2015 12
2016 13
2017 13
2018 8
2019 6
2020 9
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic challenges in meningioma.
Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M, Wick W, Sahm F. Nowosielski M, et al. Among authors: kickingereder p. Neuro Oncol. 2017 Nov 29;19(12):1588-1598. doi: 10.1093/neuonc/nox101. Neuro Oncol. 2017. PMID: 28531331 Free PMC article. Review.
Response.
Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Wick W, Schlemmer HP, Bendszus M. Radbruch A, et al. Among authors: kickingereder p. Radiology. 2016 Apr;279(1):324-5. Radiology. 2016. PMID: 27437553 No abstract available.
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio.
Nowosielski M, Ellingson BM, Chinot OL, Garcia J, Revil C, Radbruch A, Nishikawa R, Mason WP, Henriksson R, Saran F, Kickingereder P, Platten M, Sandmann T, Abrey LE, Cloughesy TF, Bendszus M, Wick W. Nowosielski M, et al. Among authors: kickingereder p. Neuro Oncol. 2018 Mar 27;20(4):557-566. doi: 10.1093/neuonc/nox162. Neuro Oncol. 2018. PMID: 29016943 Free PMC article. Clinical Trial.
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Aslan K, Turco V, Blobner J, Sonner JK, Liuzzi AR, Núñez NG, De Feo D, Kickingereder P, Fischer M, Green E, Sadik A, Friedrich M, Sanghvi K, Kilian M, Cichon F, Wolf L, Jähne K, von Landenberg A, Bunse L, Sahm F, Schrimpf D, Meyer J, Alexander A, Brugnara G, Röth R, Pfleiderer K, Niesler B, von Deimling A, Opitz C, Breckwoldt MO, Heiland S, Bendszus M, Wick W, Becher B, Platten M. Aslan K, et al. Among authors: kickingereder p. Nat Commun. 2020 Feb 18;11(1):931. doi: 10.1038/s41467-020-14642-0. Nat Commun. 2020. PMID: 32071302 Free PMC article.
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
Schell M, Pflüger I, Brugnara G, Isensee F, Neuberger U, Foltyn M, Kessler T, Sahm F, Wick A, Nowosielski M, Heiland S, Weller M, Platten M, Maier-Hein KH, Von Deimling A, Van Den Bent MJ, Gorlia T, Wick W, Bendszus M, Kickingereder P. Schell M, et al. Among authors: kickingereder p. Neuro Oncol. 2020 Nov 26;22(11):1667-1676. doi: 10.1093/neuonc/noaa120. Neuro Oncol. 2020. PMID: 32393964 Free PMC article. Clinical Trial.
71 results